跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION - HSA Drug Approval Details
Approvals
/
HSA
/
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Approved
STANDARD
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
552c27ce6b95d751
Company
Unknown
Type
Standard
Approval Details
Approval Id
552c27ce6b95d751
Drug Name
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Active Ingredients
SODIUM SELENITE ANHYDROUS
4.38 mcg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
552c27ce6b95d751
Type
Standard
Back to HSA Approvals
